1627523-17-4Relevant articles and documents
Design, synthesis and biological evaluation of type-II VEGFR-2 inhibitors based on quinoxaline scaffold
Shahin, Mai I.,Abou El Ella, Dalal A.,Ismail, Nasser S.M.,Abouzid, Khaled A.M.
, p. 16 - 26 (2014/06/24)
In an effort to develop ATP-competitive VEGFR-2 selective inhibitors, a series of new quinoxaline-based derivatives was designed and synthesized. The target compounds were biologically evaluated for their inhibitory activity against VEGFR-2. The design of the target compounds was accomplished after a profound study of the structure activity relationship (SAR) of type-II VEGFR-2 inhibitors. Among the synthesized compounds, 1-(2-((4-methoxyphenyl)amino)-3- oxo-3,4 dihydroquinoxalin-6-yl)-3-phenylurea (VIIa) displayed the highest inhibitory activity against VEGFR-2. Molecular modeling study involving molecular docking and field alignment was implemented to interpret the variable inhibitory activity of the newly synthesized compounds.